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ABSTRACT 
The objective of this study was to develop an improved selective medium for the isolation of 
Tay/ore/la sp .. It is important the United States remains free of contagious equine metritis, 
because large sums of money could be lost in the Thoroughbred industry if this organism is 
not easily detected. The currently used selective medium, Modified Timoney Shin (MTS), is 
too restrictive for growing some strains of Tay/ore/la sp. A new selective media that is more 
restrictive to growth of contaminants would ensure that laboratory personnel are able to 
isolate Tay/ore/la sp. more readily from diagnostic samples. A total of eighty-seven 
antimicrobials were evaluated using a disk diffusion test, and ten antimicrobials with the 
smallest mean zones of inhibition for Tay/ore/la sp. over three replications were chosen for 
inclusion in this study. The zones of inhibition of Tay/ore/la equigenitalis strains were 
significantly larger than the zones of inhibition of Tay/ore/la asinigenitalis strains for some of 
the antimicrobials. Combinations of antimicrobials were evaluated, and final selections were 
based on the maximum number of contaminants inhibited and on the ability to support the 
growth of T. equigenita/is and T. asinigenita/is. The combination of 320 µg/ml p-
aminosalicyclic acid, 5 µg/ml clindamycin, and 5 µg/ml amphotericin B supported the growth 
of Tay/ore/la sp., but was more inhibitory to the ten most frequent contaminants than was 
MTS. Ten individual contaminants and sixteen combinations of a single dilution of 
contaminants with Tay/ore/la sp. included in lower dilutions were plated onto the new 
medium and MTS. Fourteen contaminants were more inhibited on the new medium than on 
MTS, eleven had comparable growth on both, and there was one that grew better on the 
new medium. Twenty-two swabs from caudal reproductive tracts of horses were evaluated. 
Sixteen had less growth on the new medium than on MTS, four had comparable growth, and 
V 
two had more growth. A side by side comparison of the new media with MTS will be 
necessary to evaluate its potential to replace MTS in diagnostic testing. 
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INTRODUCTION 
Tay/ore/la equigenitalis, the etiologic agent of contagious equine metritis (CEM), was first 
described in 1977 in Thoroughbred horses in England and Ireland (33). Tay/ore/la 
equigenitalis is a microaerophilic, small Gram negative cocco-bacillus that was initially 
classified as a Haemophilus species. 
Although T. equigenitalis does not cause mortality, it causes severe economic loss in the 
horse industry through a severe reduction in the conception rate of mares (36). Tay/ore/la 
equigenitalis is an international problem not only because it causes short term infertility but 
also because the carrier state is readily established in both stallions and mares (41 ). 
Currently there are two diagnostic tests in common usage. The first test is bacteriologic 
culture in which swabs are taken from mares and stallions and plated onto agar to cultivate 
any microbes present. The second diagnostic test is the complement fixation test. 
Antibodies against T. equigenitalis in mares are present at around seven days post infection 
(Pl), reach a maximum titer three weeks Pl, and decline between six and ten weeks Pl (41 ). 
Stallions, however, typically do not develop an antibody titer even if exposed. 
"A major problem .. . is the difficulty of isolating [T. equigenitalis] ... from heavily contaminated 
sites" (40). Two bacteriologic culture media are commonly used for recovery of Tay/ore/la 
sp. from genital tract specimens of equidae destined for import, export, sale, and/or 
diagnostic testing. Eugon agar does not contain selective inhibitors and is easily overgrown 
by normal genital tract flora. In contrast, Modified Timoney-Shin agar (MTS), containing an 
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antifungal agent and two antibiotics, is too restrictive for growth of some strains of Tay/ore/la 
sp. 
Under the present system, the United States National Veterinary Services Laboratories 
(NVSL) approves state and university diagnostic laboratories for conducting CEM testing on 
imported horses. Swabs from mares (cervix, clitoral fossa, and clitoral sinus) and stallions 
(urethra, urethral fossa, and penile sheath) are submitted to diagnostic laboratories for 
culture. The horses are held in quarantine stations until testing is completed. If Tay/ore/la 
sp. are detected, horses must be treated under a specific regimen and retested before they 
are released, or they must be returned to the country of origin. If carrier horses were missed 
due to inadequate bacteriologic culture, very expensive epidemiologic tracing would be 
required to assure that all potentially exposed horses were tested. Development of a new 
selective medium which would inhibit other flora yet allow isolation of Tay/ore/la sp. would 
greatly increase proficiency in detection. The objective of this research was to develop a 
new selective medium that inhibits normal flora found in the caudal equine reproductive 
tract, but allows growth of all Tay/ore/la sp. strains. 
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LITERATURE REVIEW 
History and characteristics of Tay/ore/la equigenitalis 
Contagious equine metritis (CEM) is a venereal disease of equids that is characterized by 
an inflammation of the endometrium, with subsequent short-term loss of fertility, and 
occasional abortion. The etiological agent of CEM is Tay/ore/la equigenitalis, a small Gram-
negative microaerophilic cocco-bacillus (44). 
Contagious equine metritis was discovered in 1977 in the United Kingdom at a stud farm in 
Newmarket (37). Acute metritis and a significant reduction in conception rate developed 
among mares on the farm. Initial attempts to recover the etiological agent under aerobic 
conditions failed. When alternative culture methods were attempted, a microorganism that 
would later be named T. equigenitalis was recovered. Isolates of the microbe have since 
been reported in Japan (30), Europe (24), Australia (25), and the United States (33, 34). A 
new species was recently added to the genus Tay/ore/la (14). An organism similar to 
T. equigenitalis was recovered from two male donkeys Uacks) in Kentucky and one in 
California, and the new species has been named T. asinigenita/is. 
The Office International des Epizooties (OIE) lists T. equigenitalis in Group B diseases (23). 
Group B diseases encompass diseases which are important socio-economically and/or for 
public health in countries that are considered important in international animal trade. The 
potential cost of introduction of CEM into the U.S. Thoroughbred population has been 
estimated to range from $550 million to $1.5 billion and could result in the loss of 25,000 
jobs (13). Clinical response of mares to infection with T. equigenitalis can range from 
subclinical infection to acute endometritis, acute cervicitis, and acute vaginitis characterized 
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by profuse, grayish -white, purulent uterine discharge lasting approximately 2 weeks (37, 
42). Affected mares show no signs of systemic involvement (5). Alternately, stallions show 
no clinical signs of infection but can carry the bacterium on their external genitalia (37, 42). 
Tay/ore/la equigenitalis is a non-acid fast coccobacillus 0.7 µm wide x 0.7-1.8 µmin length 
with occasional filaments 5-6 µm long (18, 32). The organism is nonhemolytic and 
nonmotile (6). It has a small, threadlike capsule that is visible when it is stained with 
ruthenium red (32). The optimum growth temperature for this organism is 37°C; however, its 
range of tolerance for growth lies between 30°C-41 °C (18, 37). Saline inactivates the 
organism, so it should not be used in laboratory diagnostic procedures (4). It is a 
microaerophilic organism that achieves optimum growth in an atmosphere containing 5-10 
per cent v/v carbon dioxide in air (18, 37). Because plates used for growing this organism 
must be incubated and observed for 7 days, plates should be incubated in an environment 
containing 70% humidity to prevent dehydration (33) . 
The organism is basically unreactive in conventional biochemical tests, but the following 
exceptions occur: production of cytochrome oxidase, catalase, and phosphatase (37). An 
API ZYM8 test, which can be used to estimate the activities of 19 bacterial enzymes, can 
detect 5 enzymes active in T. equigenitalis, including acid phosphatase, alkaline 
phosphatase, esterase-lipase, leucine aminopeptidase, and phosphoamidase (30). It was 
initially reported that the organism's growth is enhanced by X factor, or hemin (6, 32, 37). 
Whether this is an absolute requirement remains controversial (28, 29, 30). Cellular fatty 
acid composition of T. equigenitalis was determined by gas chromatography. Fatty acid 
methyl ester (FAME) profiles have shown that T. equigenitalis contains 3 major fatty acids 
including C 18: 1, C 16:0, and 30H-C 14:0 (22). 
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There are two primary diagnostic tests used for the detection of T. equigenitalis. The first is 
the culture method, in which genital swabs are collected and plated on appropriate media. 
The second is a complement fixation test in which blood is drawn from mares and the serum 
evaluated for the presence of T. equigenitalis antibodies (23, 42, 43). Other diagnostic 
methods also have been used. Polyclonal and monoclonal antibody conjugates have been 
developed for use in direct and indirect fluorescent antibody tests, respectively (12, 20). A 
polymerase chain reaction (PCR) test was developed in 1999 (1 ), and researchers at the 
University of Kentucky developed a slide agglutination test by hyperimmunizing rabbits with 
a formalized suspension of T. equigenitalis (7). An enzyme-linked immunosorbent assay 
(ELISA) has been developed for serodiagnosis of T. equigenitalis (17). Despite the vast 
array of diagnostic tests available, culture remains the definitive tool for diagnosis (23). 
Swabs for culture should be collected and placed in Amies transport medium with charcoalb 
(27, 39). The swabs must be shipped on an ice pack or under refrigeration to an approved 
laboratory and received within 48 hours of collection (23). Individual countries have their 
own requirements for anatomical sites to be swabbed for import clearance. Sites 
traditionally swabbed from the mare include the cervix, clitoral fossa, and clitoral sinus (44). 
Mares that are chronically infected tend to harbor the organism in the clitoral sinus and 
clitoral fossa (36). The primary locations for swabbing in the stallion are the penile sheath, 
urethra and urethral fossa (44). Stallions that are chronically infected tend to carry the 
organism in the urethral fossa (36). Because of the abundance of overgrowth on plates 
when culturing stallions, it is difficult to isolate T. equigenitalis; therefore it is required that 
stallions mate with two test mares that are subsequently cultured for the organism (43). 
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Although very small colonies may be recognized after 48 hours of incubation, it takes 
approximately 72 hours to see distinct colonies of T. equigenitalis. A typical colony 
appearance is round, convex, shiny cream-colored to brown, and 0.25 mm to 1 mm in 
diameter at 48 hours on Eugen chocolate agar (28). Colonies are also described as being 
raised and pinpoint with a smooth, butyrous texture at 48-72 hours on chocolate agar 
prepared with horse blood (18). 
Tay/ore/la asinigenitalis has a slower growth rate and produces only a weak reaction in the 
indirect fluorescent antibody test for T. equigenitalis. Infected jacks also exhibit a serological 
response to the new species, contrary to what is observed in stallions infected with 
T. equigenita/is. The DNA encoding the 16S rRNA of T. asinigenita/is has been sequenced 
and analyzed and is genetically different from T. equigenitalis. Tay/ore/la equigenitalis and 
T. asinigenitalis are 97.6% homologous. 
Transmission of the agent 
In most cases CEM is spread through breeding (natural service or artificial insemination) of 
an infected (carrier) animal to an uninfected animal. It is possible for an animal to be 
infected via fomites, (e.g., vaginal specula), or through inadequate hygiene precautions by 
personnel who handle mares and stallions at breeding (42). 
In a recent study mares were experimentally challenged by vaginal infusion with strains of 
Tay/ore/la sp. from Germany, Great Britain, Kentucky, and California (16). The German 
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(T. equigenitalis), Great Britain (T. equigenitalis), and Kentucky jack (T. asinigenitalis) 
strains caused disease in the mares; however, the California (T. asinigenitalis) jack isolate 
did not result in clinical disease. The mares infected with the Kentucky strain of 
T. asinigenitalis developed infection several days later, but had a less severe infection, than 
mares infected with the classical strains of T. equigenitalis. The organism used to inoculate 
the mares was recovered from all females 111 days post-exposure. 
Prevention and Control 
There is no effective vaccine currently licensed worldwide for contagious equine metritis 
(42). Thus, the primary method of controlling T. equigenitalis is by preventing transmission 
between horses (23). To prevent the transmission of T. equigenitalis, infected horses must 
be accurately identified. Because serum antibodies against T. equigenitalis can be detected 
in mares for 3-7 weeks following clinical disease, but are usually absent in carrier mares, 
serological tests are of more value in recent than in chronic infections. Considering that, 
and the fact that antibodies are rarely detected in stallions, the serologic test isn't as reliable 
as the culture method as a diagnostic tool. 
Selective media used for isolation 
Samples initially taken to search for the etiologic agent of CEM were inoculated onto blood 
agar, chocolate (heated blood) agar and MacConkey agar (37). Chocolate agar supported 
the growth of the T. equigenitalis after 48 hours of incubation, whereas no growth was seen 
on either blood agar or MacConkey agar. Other media were subsequently evaluated to 
determine optimum conditions for growth of T. equigenita/is, and Columbia chocolate agar 
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was determined to be the preferred medium. Later, Eugen agar with horse blood was 
compared with tryptose chocolate agar and determined to "greatly improve the recovery" of 
T. equigenitalis (11 ). 
Eugen plates, however, may be heavily overgrown at 24 hours; therefore, a selective 
medium was developed to be used in addition to the noninhibitory (Eugen) plate (37). The 
selective plate had the same base as the noninhibitory plate, but included 100 mg/I of 
streptomycin to prevent overgrowth . Two biotypes of T. equigenitalis have been described, 
one that is sensitive and one that is resistant to streptomycin (7) . For this and other reasons 
(see below}, streptomycin is no longer added to basic medium used for diagnostic purposes 
(40) . 
When Escherichia coli and T. equigenitalis are inoculated together on Eugen agar with 10% 
chocolate horse blood, complete inhibition of T. equigenitalis can occur unless streptomycin 
is included in the medium to inactivate the E. coli (2) . When dextrose was removed from the 
agar, however, the antagonism disappeared. Because dextrose isn't a requirement for 
growth of T. equigenitalis and affects only the antagonistic organisms, media without 
dextrose are now recommended for isolating T. equigenitalis. An alternative to using a 
Eugon base without dextrose is to add 0.3 g/I of L-cystine and 0.3 g/I of sodium sulphite, 
which will augment growth of T. equigenitalis, to Columbia agar or blood agar base No. 2 . 
In 1978 when CEM was first diagnosed in the United States, the best formula for the 
selective plate was 200 µg/ml of streptomycin , 5 µg/ml of amphotericin B, and 1 µg/ml of 
crystal violet added to a chocolate agar plate with a Eugon agar base and 10% horse blood 
(33, 34). The new formula discouraged growth of contaminants and did not inhibit the growth 
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of streptomycin-resistant strains. A noninhibitory chocolate agar plate containing Eugen 
agar base and 10% horse blood should be used in addition to the selective plate to isolate 
any streptomycin sensitive strains. 
Other problems have been encountered with media used for isolation of T. equigenitalis. 
Some field strains did not grow on certain lots of commercially prepared chocolate agar (35). 
Inadequate heating for the proper time period was subsequently identified as the reason for 
the problems. Twenty-five percent of the blood should be added to the agar and heated for 
15 minutes at 80°C. The blood turns a light brown color, and floccules form. The other 75% 
of the blood should be added after the medium is cooled to 45°C in a waterbath. 
In 1983, it was discovered that the addition of lsovitalexc to Eugen agar with 5% chocolate 
horse blood and 5% percent lysed horse blood without added glucose was unnecessary (3). 
The lsovitalexc (a mixture of amino acids, nucleotides, vitamin B complex, and minerals) did 
not have a significant growth promoting effect on T. equigenitalis; therefore it could be 
excluded without altering the outcome. 
There are two types of media currently recommended by the National Veterinary Services 
Laboratories for isolation of T. equigenitalis. Eugen agar with 10% chocolate horse blood is 
a noninhibitory medium. Modified Timoney-Shin agar is an inhibitory medium that contains 
1 µg/ml of trimethoprim, 5 µg/ml of clindamycin, and 5 µg/ml of fungizone to inhibit 
overgrowth by normal flora (20). A liquid medium with a Eugen base (without agar or horse 
blood) that allows T. equigenitalis to be propagated in large quantities was developed (10). 
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Antimicrobial susceptibility profiling 
Table 1 details previously published antimicrobial susceptibility of T. equigenitalis isolates 
from various countries between 1977 and 1993. There were some differences among 
authors regarding susceptibility of the isolates to thirteen of the sixty-nine (18.8%) 
antimicrobials: neomycin, streptomycin, trimethoprim, clindamycin, lincomycin, novobiocin, 
cloxacillin, penicillin, cotrimoxazole, sulphadimethoxine, sulphamethoxazole, minocycline, 
and oxytetracycline. For example, penicillin resistance was reported in 90% of isolates in 
one study, but this finding differed from seven other studies which reported T. equigenitalis 
isolates as susceptible to penicillin (9). This difference may be due to the use of a 
breakpoint (0.15 µg/ml) that may have been lower than that used in other studies. 
Unfortunately, other authors did not provide breakpoints used in their research. 
Another problem in comparing and interpreting published antimicrobial susceptibility results 
is lack of uniformity among studies. Four authors did not state results in terms of 
percentage of susceptible isolates, but reported results as either susceptible, intermediate, 
or resistant for a given antimicrobial (24, 26, 37, 38). One author used a minimum inhibitory 
concentrations100 (MIC) and stated that 100% of strains tested were found to be either 
susceptible or resistant to a given antimicrobial (41 ). Five authors used MIC50 and MIC90 
and stated that 50% or 90% of strains were found to be either susceptible or resistant to a 
specific antimicrobial (6, 8, 9, 15, 31 ). 
All strains of T. equigenitalis tested against metronidazole have been classified as resistant. 
Tay/ore/la equigenitalis has been considered to be susceptible to aminoglycosides with the 
exception of streptomycin and its analogue, dihydrostreptomycin. In most cases 
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T. equigenitalis was susceptible to tetratcyclines, with the exception of one study in which 
T. equigenita/is was resistant to minocycline and oxytetracycline (9). In addition, 
T. equigenitalis was susceptible to macrolides, nitrofurans, and polymyxins. 
The most variability of T. equigenitalis responses within a group of antimicrobials occurred 
with sulfonamides and sulfonamide combinations. The research strains vary from being 
susceptible to baquiloprim/sulphadimidine, intermediate to variable to sulphadimethoxine, 
and resistant to sulphatroxazole. 
Need for improved selective medium 
The current selective medium used for isolation of T. equigenitalis needs improvement. 
Problems such as overgrowth of selective plates and inhibition of some of the more 
fastidious strains are issues at many laboratories. Selective plates are often too inhibitory 
for the more fastidious strains of Tay/ore/la sp. , especially T. asinigenitalis, and Eugen 
plates can be heavily overgrown by normal flora, thus making isolation of Tay/ore/la sp. from 
heavily contaminated sites difficult to impossible. An improved selective medium would 
increase chances of isolating Tay/ore/la sp. from diagnostic samples containing low 
numbers of the bacteria and thereby increase the probability that all positive animals would 
be readily and easily detected. That would provide added assurances that the U.S. will 
maintain its negative status for T. equigenita/is. 
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Table 1. Susceptibility of different strains of Tay/ore/la equigenitalis to various antimicrobials agents 
Antimicrobial Reference Number 
6 8 9 15 24 26 31 37 38 41 
Aminoglycosides 
Amikacin s s s s s 
Amino deoxv-kanamycin s 
Dihydrostreptomycin R 
Furaziomycin s 
Gentamycin s s s s s s s 
Kanamycin s s s s s s s 
Neomycin s s s I or R s s s 
Streptomycin 17%strains S R R R I or R R R R 
Spectinomycin s 
Tobramycin s s s s s 
Viomycin I or R 
Ceohalosoorins 
Cefazolin s s 
Cefotaxime s 
Cephaloridine s s 
Cephalothin s s s s 
Cephamycins 
Cefotetan s 
Diaminooyrimidines 
Aditoprim R 
Baouiloprim R 
Trimethoprim 30%strains S I R R 
Lincosamides 
Clindamycin R I I or R R 
Lincomycin R I I or R Ltd activity R 
Macrolides/Rifamycins 
Ervthromycin s s s s s s s 
Josamycin s 
Kitasamycin s s 
Oleandomycin s s s 
Rifampin I or R 
Spiramycin s s 
Tylosin s 
Nitrofurans/Nitroimidazoles 
Furazolidone s s s s s 
Metronidazole R R R 
Nitrofurantoin s s s 
Other 
Bacitracin s s s s 
Chloramphenicol s s s s s s s s s 
Flavophospholipol s 
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Table 1. Continued 
Antimicrobial Reference Number 
Other 6 8 9 15 24 26 31 37 38 41 
Fusidic acid s s s 
Mandelamine I or R 
Novobiocin s I or R s 
Tiamulin s 
Thiamphenicol s s 
Vancomycin I or R 
Penicillins 
Amoxicillin s 
Ampicillin s s s s s s s s 
Carbenicillin s s s 
Cloxacillin R R I 
Dicloxacillin lows 
Methicillin I or R 
Penicillin s s R s s s s mod. S 
Polymvxins 
Colistin 94% strains S s s s 
Polymyxin B s s s s s s 
Quinolones/Fluroquinolones 
Ciprofloxacin s 
Enrofloxacin s 
Flumeauine s 
Nalidixic acid s s s s s s 
Oxolinic acid s s 
Sulfonamides/Combinations 
Baauiloprim/sulphadimidine s 
Cotrimoxazole s I 
Sulphadiazine R 
Sulphadimidine R 
Sulphadimethoxine I Var. Var. 
Sulfadoxine/trimethoorim s 
Su lo hamethoxazole s R 
Sulohatroxazole R 
Trimethoprim/sulphadiazine s 
Trimethoprim/sulphatroxazole s 
Tetracyclines 
Chlortetracvcline s s s s 
Doxvcvcline s s 
Minocvcline R s 
Oxvtetracvcline s R s s s 
Tetracycline s s s s s 
.. S=sens,tive, R=res,stant, l=mtermed1ate, mod=moderately, var=vanable, Ltd=hm,ted 
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MATERIALS AND METHODS 
Organisms 
Isolates of Tay/ore/la equigenita/is (n=29) and Tay/ore/la asinigenita/is (n=5) were identified 
by personnel at the National Veterinary Services Laboratories (Ames, Iowa, U.S.A.) or 
received as type strains (Table 2). Tay/ore/la sp. were isolated between 1977 and 2002 and 
were stored at -70°C in trypticase soy broth with 20% glycerol, or in blood, until tested. 
Antimicrobial Susceptibility Testing of Tay/ore/la species 
Disk Diffusion 
The Tay/ore/la organisms were plated on Eugen agar with 10% chocolate horse blood (15 x 
100 mm) and incubated for 72 hours at 37°C in 10% v/v CO2. After 48 hours of incubation, 
sterile cotton tipped swabs were used to transfer colonies to sterile tubes of distilled water. 
Bacterial cell densities were adjusted to a 0.5 McFarland standard, using a Sensititre 
nephelometer (Trek Diagnostic Systems, Inc. Cleveland, OH). The standardized cultures 
were swabbed onto a Eugen agar plate (15x150mm). The same swab was then dipped 
twice more and the procedure repeated by streaking the plate at a right angle to the 
previous inoculation to obtain a lawn growth of the organism. Eighty-seven antimicrobial 
discs (Hardy Diagnostics, Santa Maria, CA, BBL, Cockeysville, MD, Remel , Lenexa, KS 
Oxoid, Ogdensburg, NY) (Table 3) were then placed on the plates with a BBL self tamping 
dispenser (BBL, Cockeysville, MD), using 6 antimicrobial disks per plate. Plates were 
incubated for 48 hours at 37°C in 10% v/v CO2. Zones of inhibition were measured in 
15 
millimeters with a standard ruler at 48 hours post inoculation. Three repl ications of each 
isolate-antimicrobial combination were performed, and means of the 3 replications were 
calculated. Quality control organisms for each antimicrobial (Table 4) were inoculated onto 
Mueller Hinton agar plates and incubated for 24 hours at 3TC in 0 2, using 12 antimicrobial 
disks per plate, according to NCCLS guidelines (21 ). Inhibition zone measurements were 
compared to expected values from quality control organisms to verify the antimicrobial disks 
accuracy. Based on the smallest mean inhibition zones, ten antimicrobials were selected as 
candidates for agar dilution testing. 
Agar Dilution 
The agar dilution method was utilized to obtain the MIC of Tay/ore/la sp. for each of the ten 
selected antimicrobials. Eugon agar with 10% chocolate horse blood was used as the basal 
medium, and 3 replications of Tay/ore/la sp. were plated onto each antimicrobial agar 
dilution plate. Because there are no known MIC values for Tay/ore/la species, a broad 
range of dilutions was used initially for ethambutol, isoniazid , metronidazole, p-
aminosalicyclic acid , nafcillin, and oxacillin. From those data, a narrower range was used to 
determine the exact MIC. For clindamycin, lincomycin, amphotericin B, cloxacillin, and 
trimethoprim, MIC data were available. 
Bacterial cell densities were adjusted to a 0.5 McFarland standard for each of the 34 
isolates as previously described, according to NCCLS guidelines (21). Plates were placed 
agar side up in a 3TC incubator for 10 minutes with the lids slightly ajar to dry excess 
moisture from the surfaces. A Cathra replicator (Oxoid, Inc., Nepean, Ontario, Canada) was 
used to deliver a 2 µI inoculum of 12 isolates per 15x 100 mm petri plate. Plates were 
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allowed to dry for 5 to 10 minutes with the lids slightly ajar. Lids were replaced and plates 
inverted and incubated at 3TC in 10% v/v CO2 for 48 hours. 
The MIC for all antimicrobial agents was defined as the lowest concentration of antimicrobial 
that completely prevented growth. The MIC level was chosen from the lowest value of the 
three replications for the Tay/ore/la sp. against each antimicrobial. For example, if the 
lowest value among the strains of Tay/ore/la sp. was 320 µg/ml for the first replication, 320 
µg/ml for the second replication, and 160 µg/ml for the third replication the value of 160 
µg/ml was chosen as the MIC to ensure that all Tay/ore/la sp. would grow. Quality control 
organisms (Table 4) with known MIC values for each antimicrobial were used to determine if 
the correct concentrations were incorporated into the basal medium for each dilution. There 
is no quality control data for cloxacillin, ethambutol, lincomycin, isoniazid, and p-
aminosalicyclic acid. For each of those antimicrobials five quality control strains were used 
for each replication. None of the antimicrobials had specific guidelines when using a Eugen 
base or a CO2 environment. 
When the trimethoprim and clindamycin were incorporated into the Eugen base and 
incubated in CO2, they did not produce the known MIC value for the quality control 
organisms. Due to the lack of conformity to known standards, an alternative method was 
utilized. When the stock solution was made not only was it incorporated into Eugen plates 
for the Tay/ore/la sp., but also it was incorporated into Mueller Hinton plates for use with the 
quality control organisms. The quality control organisms were placed on the Mueller Hinton 
plates, incubated in 0 2, and read at 24 hours. 
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Recovery of Contaminants from Equine Reproductive Tract 
To determine which organisms are present in the caudal equine reproductive tract and, 
therefore, which organisms need to be inhibited, frozen diagnostic swabs were obtained. 
Swabs were requested specifically for this project from Cornell University's Animal Health 
Diagnostic Laboratory, University of Kentucky's Livestock Disease Diagnostic Center, and 
University of Cal ifornia 's Animal Health and Food Safety Laboratory System. These swabs 
were taken from horses designated for import or export testing . The swabs were shipped to 
the various diagnostic laboratories on ice packs, plated on media for diagnostic testing, and 
frozen at -70°C for later shipment to the National Veterinary Services Laboratories. Swabs 
were collected for a period of one month and then shipped overnight on dry ice to the 
National Veterinary Services Laboratories. 
In addition, diagnostic swabs submitted to the National Veterinary Services Laboratories for 
isolation of Tay/ore/la sp. were saved and frozen at -70°C for later use. Swabs were thawed 
overnight at 5°C and rolled onto Eugen agar plates with 10% chocolate horse blood and 
streaked for isolation of colonies. Plates were incubated for 24 hours at 37°C in 10% v/v 
CO2. A variety of colony types was seen on each of the plates. All of the different colonies 
from each swab were picked onto a Eugen agar slants with 10% chocolate horse blood. 
Slants were incubated for 24 hours at 37°C in 10% v/v CO2. Growth from each was 
suspended in trypticase soy broth with 20% glycerol and stored at -1o·c in a sterile 2 ml 
cryo vial (Sarstedt, NOmbrecht, Germany) for isolate identification and antimicrobial 
sensitivity testing at a later date. 
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Identification of Contaminants 
Stored isolates were plated onto heart infusion agar with 1 % yeast and 5% bovine blood and 
incubated aerobically for 24 hours at 37°C. Single colonies were picked onto heart infusion 
agar slants containing 1 % yeast and 5% bovine blood and triple sugar iron slants. They 
were incubated aerobically for 24 hours at 37°C. Gram stains, as well as oxidase and 
catalase tests, were performed. A 0.5 McFarland Standard of each isolate was prepared as 
previously described. Sensititre AP80 Gram negative identification and AP90 Gram positive 
identification plates (Trek Diagnostic Systems, Inc. Cleveland, OH) were inoculated using 
the Sensititre auto-inoculation system. Plates were incubated aerobically for 24 hours at 
37°C and read using the Sensititre auto-reader (Trek Diagnostic Systems, Inc. Cleveland, 
OH). 
Antimicrobial Susceptibility Testing of Contaminants 
A 0.5 McFarland Standard of each of the ten most frequently identified contaminants from 
this project was made as previously described. Eugen agar with 10% chocolate horse blood 
was used as the basal medium. Varying dilutions of stock solutions were made and 
individually incorporated into the basal medium up to and including the MIC level for 
Tay/ore/la sp .. If the level of antimicrobial required to inhibit the contaminant was greater 
than the MIC level for Tay/ore/la sp., it was recorded as greater than the MIC value (e.g., 
>1280 µg/ml). Plates were dried, and a Cathra replicator (Oxoid, Inc., Nepean, Ontario, 
Canada) was used to deliver a 2 µI inoculum of each of the ten contaminants onto the 
plates, using 10 strains per plate. Plates were allowed to dry, lids were replaced, and plates 
were inverted and incubated at 37°C in 10% v/v CO2 for 24 hours. Results were recorded 
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for each antimicrobial agent against each contaminant, and 3 replications were performed. 
Antimicrobials that allowed Tay/ore/la sp. to grow, but inhibited the growth of the 
contaminants, were considered as candidates for incorporation into a new selective 
medium. 
Selection of Antimicrobial Combinations 
Based on their individual ability to inhibit the growth of the maximum number of 
contaminants, three antimicrobials were incorporated into a Eugen base in different 
combinations (Table 5). The first combination of antimicrobials was p-aminosalicyclic acid, 
lincomycin, and amphotericin B. The second combination of antimicrobials was p-
aminosalicyclic acid, clindarnycin, and amphotericin B. The levels of p-aminosalicyclic acid 
were varied in each set of antimicrobial combinations with the concentration of the other 
antimicrobial agents being held constant. The third combination of antimicrobials was 
clindamycin and amphotericin B. Two different levels of clindamycin were used, but the 
concentration of amphotericin B remained the same. 
Evaluation of Antimicrobial-Supplemented Media with Tay/ore/la sp. and specified 
contaminants 
A 1 0 µI loop of the 10 contaminants and the two Tay/ore/la strains were streaked individually 
onto MTS plates and plates containing the 8 new combinations of antimicrobials (a total of 9 
plates for each of the 12 organisms). Plates were incubated at 37°C in 10% v/v CO2 and 
checked each day for seven consecutive days. The antimicrobial combinations that showed 
the greatest inhibition of the contaminants and the least inhibition of the Tay/ore/la sp. were 
selected based on the quadrant of the plate into which growth extended. For example, if 
20 
growth was limited to the first quadrant it would be scored a 1 +, as opposed to growth that 
extended into the fourth quadrant scoring a 4+. Scores were compared to determine the 
number of plates which had the least growth. 
Because it would be unlikely to find ten contaminants in a single diagnostic sample, three 
contaminants and one strain of Tay/ore/la sp. were combined to represent diagnostic 
samples. Combinations of the contaminants were frozen in trypticase soy broth with 20% 
glycerol and stored at -70°C. Sixteen combinations of various contaminants and dilutions of 
Tay/ore/la sp. were made (Table 6). A 0.5 McFarland Standard of each of ten contaminants 
was made as previously described. Serial dilutions were made, and 100 µI was plated onto 
each of two Eugen agar with 10% chocolate horse blood plates to obtain the number of 
colony forming units per ml (CFU/ml). Plates were incubated for 24-48 hours and colony 
counts made. Three contaminants and varying dilutions of either T. equigenitalis or 
T. asinigenitalis were frozen with known values of CFU/ml for each of 16 combinations. 
A 1 0 µI loop of each combination was plated onto the antimicrobial combination which 
showed the greatest inhibition of the contaminants and the least inhibition to the Tay/ore/la 
sp., and onto a MTS plate (Table 5) . Plates were read at days 1, 3, 4, 5, and 7. Plates were 
scored by the quadrant in which growth occurred. Because Tay/ore/la sp. do not require 
glucose for growth and several contaminants grow better in the presence of it, glucose was 
not included in the basal medium in which the antimicrobial combinations were incorporated. 
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Testing of Antimicrobial-Supplemented Media with Diagnostic Samples 
In order to test the effectiveness of the new antimicrobial combination to inhibit 
contaminants in samples collected from live horses, twenty-two swabs were taken from 8 
horses at the Iowa State University Animal Science Department horse barn. Swabs were 
taken from the cervix (if not pregnant), clitoral fossa, and clitoral sinus of mares and from the 
urethra, urethral fossa , and diverticulum of a stallion and placed deep in Amies transport 
medium with charcoal (Copan, Brescia, Italy). Swabs were transported on ice to the 
National Veterinary Services Laboratories. Each swab was rolled onto a MTS plate and a 
plate containing 320 µg/ml p-aminosalicyclic acid, 5 µg/ml clindamycin, and 5 µg/ml 
amphotericin B. Plates were read at 24 hour intervals for seven consecutive days and 
scored based on the quadrant into which growth extended. 
Data Analysis 
Data were analyzed using SAS (Statistical Analysis Software, Version 8.0, 2002). P-values 
were obtained using Wilcoxon Rank Sum nonparametric statistical test instead of a standard 
t-test because the data were not normally distributed. In addition, the values were the result 
of independent random samples as required by the Wilcoxon Rank Sum test. 
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Table 2. Tay/ore/la sp. used in study 
Number Country of origin Name 
1 England T. equigenita/is 
2 Germany T. equigenitalis 
3 Japan T. equigenitalis 
4 Czech Rep T. equigenitalis 
5 Germany T. equigenitalis 
6 Germany T. equigenitalis 
7 Germany T. equigenitalis 
8 England T. equigenitalis 
9 Austria · T. equigenitalis 
10 Germany T. equigenitalis 
11 Germany T. equigenitalis 
12 Germany T. equigenitalis 
13 US-Kentucky T. asinigenitalis 
.14 US-Kentucky T. asinigenitalis 
15 Germany T. equigenitalis 
16 US-Kentucky T. asinigenitalis 
17 Netherlands T. equigenitalis 
18 England T. equigenitalis 
19 US-Kentucky T. asinigenita/is 
20 France T. equigenita/is 
21 Germany T. equigenitalis 
22 US-California T. asinigenitalis 
23 Belgium T. equigenitalis 
24 Germany T. equigenitaiis 
25 Germany T. equigenitalis 
26 U.K. T. equigenitalis 
27 U.K. T. equigenitalis 
28 Germany T. equigenita/is 
29 Germany T. equigenitalis 
30 Netherlands T. equigenitalis 
31 Germany T. equigenitalis 
32 Germany T. equigenitalis 
33 Netherlands T. equigenitalis 
34 Netherlands T. equigenitalis 
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Table 3. Antimicrobial Disk Concentrations 
Concentration 
Antimicrobial Concentration /ual Antimicrobial ( I l(]) 
Aminoqlvcosides Other 
Amikacin 30 Bacitracin 10 
Gentamvcin 10 Chloramphenicol 30 
Kanamycin 30 Ethambutol 25 
Neomycin 30 lsoniazid 1 
Netilmicin 30 Novobiocin 30 
Streptomycin 10 o-aminosalicyclic acid 10 
Spectinomycin 100 Vancomycin 30 
Tobramycin 10 Penicillins 
Carbaoenems Amindocillin 10 
lmipenem 10 Amoxicillin w/ clavulanic acid 30 
Cephalosporins Ampicillin 10 
Cefaclor 30 Amoicillin w/ sulbactam 20 
Cefamandole 30 Azlocillin 75 
Cefazolin 30 Aztreonam (related to B-lactamsl 30 
Cefepime 30 Carbenicillin 100 
Cefixime 5 Cloxacillin 1 
Cefonicid 30 Methicillin 5 
Cefoperazone 75 Mezlocillin 75 
Cefotaxime 30 Nafcillin 1 
Cefpodoxime 10 Oxacillin 1 
Cefprozil 30 Penicillin 10 
Ceftazidime 30 Piperacillin 100 
Ceftiofur 30 Ticarcillin 75 
Ceftizoxime 30 Polvmvxins 
Ceftriaxone 30 Colistin 10 
Cefuroxime 30 Polymyxin B 300 
Ceohalothin 30 Quinolones/Fluroauinolones 
Loracarbef 30 Cinoxacin 100 
Moxalactam 30 Ciorofloxacin 5 
Ceohamvcins Enrofloxacin 5 
Cefmetazole 30 Enoxacin 10 
Cefotetan 30 Levofloxacin 5 
Cefoxitin 30 Lomefloxacin 10 
Diaminoovrimidines Nalidixic acid 30 
Trimethoprim 5 Norfloxacin 10 
Lincosamides Ofoxacin 5 
Clindamycin 2 Oxolinic acid 2 
Lincomvcin 2 Soarfloxacin 5 
Macrolides/Rifamycins Trovafloxacin 10 
Azithromvcin 15 Sulfonamides/Combinations 
Clarithromycin 15 Sulfachlorooyridazine 0.25 
Ervthromycin 15 Sulfadimethoxine w/ ormetoorim 1.2 
Rifampin 5 Sulfisoxazole 2 
Tilmicosin 15 Sulohamethoxazole w/ trimethoorim 23.75/1.25 
Nitrofurans/Nitroimidazoles Triole Sulfa 1 
Furazolidone 100 Tetracyclines 
Metronidazole 50 Doxvcvcline 30 
Nitrofurantoin 100 Minocycline 30 
Nitrofurazone 100 Oxvtetracycline 30 
Tetracycline 30 
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Table 4. Quality Control Organisms 
Organism name ATCC No. Method 
Bacteroides fraqilis 25285 aaar dilution 
Enterococcus faecalis 29212 agar dilution 
Escherichia coli 25922 disk diffusion and aaar dilution 
Escherichia coli 35218 agar dilution 
lssatchenkia orientalis 6258 aaar dilution 
Pseudomonas aeruqinosa 27853 disk diffusion and aaar dilution 
Staphylococcus aureus 25923 disk diffusion 
Staphylococcus aureus 29213 agar dilution 
Table 5. Combinations of Antimicrobials 
Combination 1: Combination 2: continued 
Dilution#1 Dilution#2 
320 µg/ml p-aminosalicyclic acid 160 µg/ ml p-aminosalicyclic acid 
10 µg/ml lincomycin 5 ua/ml clindamycin 
5 ug/ml amphotericin B 5 ua/ml amphotericin B 
Dilution #2 Dilution#3 
160 ua/ ml p-aminosalicvclic acid 80 µq/ml p-aminosalicvclic acid 
10 ua/ml lincomycin 5 µq/ml clindamycin 
5 µg/ml amphotericin B 5 µg/ml amphotericin B 
Dilution #3 Combination 3: 
80 ua/ ml p-aminosalicyclic acid 
10 ua/ml lincomycin Dilution#1 
5 ua/ml amphotericin B 5 ua/ml clindamycin 
5 ua/ml amphotericin B 
Combination 2: 
Dilution#2 
Dilution#1 10 ua/ml clindamycin 
320 µq/ml p-aminosalicyclic acid 5 ua/ml amphotericin B 
5 ua/ml clindamycin 
5 ua/ml amphotericin B 
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Table 6. Dilutions from a 0.5 McFarland Standard of 
Contaminants used for Combinations 
Contaminant* 
1 2 3 4 5 6 
Combination 1 10-4 10-3 10-4 
Combination 2 10-4 10-3 10-4 
Combination 3 10-4 10-3 10-4 
Combination 4 10-4 10-3 10-4 
Combination 5 10-4 10-3 10-2 
Combination 6 10-4 10-3 10-2 
Combination 7 10-4 10-3 10-2 
Combination 8 10-4 10-3 10-2 
Combination 9 
Combination 10 
Combination 11 
Combination 12 
Combination 13 10-4 10-3 
Combination 14 10-4 10-3 
Combination 15 10-4 10-3 
Combination 16 10-4 10-3 
*1 = Staphylococcus aureus, 2= Staphylococcus haemolyt,cus; 
3= non hemolytic Streptococcus sp.; 4= Escherichia coli; 5= Enterobacter aerogenes; 
6= Micrococcus sp. ; 7= Enterococcus sp.; 8= Moraxella osloensis; 
9= Streptococcus equi ssp. zooepidemicus; 1 O= Staphylococcus xylosus 
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Table 6. Continued 
Contaminant* 
7 8 9 10 T. equigenitalis (10) T. asinigenitalis (22) 
Combination 1 10-0 
Combination 2 10-4 
Combination 3 10-0 
Combination 4 10-4 
Combination 5 1ffb 
Combination 6 10-4 
Combination 7 10-0 
Combination 8 10-4 
Combination 9 10-3 10-3 10-4 10-0 
Combination 10 10-3 10-3 10-4 10-4 
Combination 11 10-3 10-3 10-4 10-0 
Combination 12 10-3 10-3 10-4 10-4 
Combination 13 10-3 10-b 
Combination 14 10-3 10-4 
Combination 15 10-3 10-0 
Combination 16 10-3 10-4 
*1 = Staphylococcus aureus, 2= Staphylococcus haemolyt1cus; 
3= non hemolytic Streptococcus sp.; 4= Escherichia coli; 5= Enterobacter aerogenes; 
6= Micrococcus sp.; 7= Enterococcus sp.; 8= Moraxella osloensis; 
9= Streptococcus equi ssp. zooepidemicus; 1 O= Staphylococcus xylosus 
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RESULTS 
Antimicrobial Susceptibility Testing of Tay/ore/la sp. 
Disk Diffusion 
The ten antimicrobials with the smallest mean zones of inhibition (6.00-14.40 mm) for three 
replications were identified after disk diffusion testing of Tay/ore/la sp .. These antimicrobials 
included metronidazole, p-aminosalicylic acid, trimethoprim, cloxacillin, oxacillin, nafcillin, 
clindamycin, ethambutol, isoniazid, and lincomycin (Table 1, Appendix A). Disk diffusion 
testing with T. asinigenitalis revealed that the zone of inhibition of T. equigenitalis was 
significantly different than the zone of inhibition of strains of T. asinigenitalis for the 
antimicrobials listed in Table 2, Appendix A This indicates that T. asinigenitalis is more 
sensitive to clindamycin, cloxacillin, isoniazid, lincomycin, nafcillin, and oxacillin than is 
T. equigenitalis. 
Agar Dilution 
The MIC values for each of the ten antimicrobials, as well as amphotericin B, were 
determined and results are listed in Table 7. 
Identification of Contaminants from Equine Reproductive Tract 
Sensititre identified 30 microorganisms from swabs of the equine reproductive tract (Table 3, 
Appendix A). The ten most frequently identified contaminants from the equine reproductive 
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tract were Staphylococcus aureus , Staphylococcus haemolyticus , non-hemolytic 
Streptococcus sp., Escherichia coli, Enterobacter aerogenes, Micrococcus sp., 
Enterococcus sp. , Moraxella osloensis, Streptococcus equi ssp.zooepidemicus, and 
Staphylococcus xy/osus (Trek Diagnostic Systems, Inc. Cleveland, OH). Isolates were 
preliminarily identified by Sensititre Microbiology Systems AP80 Gram negative identification 
plates and AP90 Gram positive identification plates (Trek Diagnostics Systems, Inc. 
Cleveland, OH) and verified by additional conventional biochemical tests (19). The 
Sensititre did not identify some isolates (Trek Diagnostics Systems, Inc. Cleveland, OH). 
Antimicrobial Susceptibility Testing of Contaminants 
To determine if the contaminant could be inhibited by levels of antimicrobial less than the 
MIC value of Tay/ore/la sp., inhibition values for the ten most frequently identified 
contaminants and amphotericin B were determined for each antimicrobial (Table 4, 
Appendix A) . All antimicrobials except for amphotericin B and trimethoprim inhibited the 
contaminants at levels that did not inhibit the Tay/ore/la sp., and they were selected as 
possibilities for inclusion into a new selective medium (Table 5, Appendix A). 
Selection of Antimicrobial Combinations 
Eight antimicrobial combinations were prepared on the basis of which individual 
antimicrobial inhibited the maximum number of contaminants. The antimicrobials included 
lincomycin , clindamycin , p-aminosalicyclic acid, and amphotericin B (Table 5, Appendix A) . 
Although amphotericin B did not inhibit any of the ten most frequently identified 
contaminants, it was included because of its anti-fungal properties. Typically, the level of 
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antimicrobial included in media is two dilutions below the MIC. Since the MICs of oxacillin, 
nafcillin, and cloxacillin were 1.25 µg/ml, <0.625 µg/ml, and <0.625 µg/ml, respectively, the 
recommended levels would be 0.3125 µg/ml , 0.15625 µg/ml, 0.15625 µg/ml , respectively, 
which are small volumes to measure. In addition, other antimicrobials were able to inhibit 
the same contaminants as oxacillin, nafcillin, and cloxacillin so they were excluded as 
candidates for inclusion. 
Evaluation of Antimicrobial-Supplemented Media with Tay/ore/la sp. and specified 
contaminants 
One isolate of T. equigenitalis, one isolate of T. asinigenitalis, and the ten most frequently 
identified contaminants were streaked individually onto plates which contained different 
combinations of antimicrobials and on MTS for comparison (Table 5) . The plates were rated 
based on the quadrant into which the growth extended (Table 6, Appendix A). The 
combination 2/dilution 1 (320 µg/ml p-aminosalicyclic acid, 5 µg/ml clindamycin, and 5 µg/ml 
amphotericin 8) inhibited the highest number of contaminants, but allowed uninhibited 
growth of Tay/ore/la sp., and was selected for further evaluation. 
In addition to one isolate of T. equigenitalis, one isolate of T. asinigenitalis, and the ten most 
frequently identified contaminants, sixteen combinations of the contaminants (Table 6) with 
low levels of Tay/ore/la sp. were streaked onto combination 2/dilution 1 and MTS. These 
plates were rated by the quadrant in which growth occurred (Table 7, Appendix A). Out of 
ten contaminants and sixteen combinations of contaminants, fourteen (53.8%) had less 
contaminant growth on combination 2/dilution1 than on MTS. Eleven (42.3%) had 
comparable growth on each medium, and one (3.8%) had more growth on combination 
2/dilution 1 than on MTS. These results indicate that combination 2/dilution 1 was more 
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effective at inhibiting individual contaminants, inhibiting combinations of contaminants, and 
allowing growth of Tay/ore/la sp. than was MTS. 
Test of Antimicrobial-Supplemented Media with Diagnostic Samples 
Diagnostic swabs were streaked on MTS and combination 2/dilution 1. Growth was 
evaluated based on the quadrant of the plate into which growth occurred (Table 8, Appendix 
A). Out of the twenty-two swabs, sixteen (72.7%) had less growth of contaminants on the 
new combination than on MTS. Four (18.1 %) had comparable growth on each medium, and 
two (9.1 %) had more growth on the new combination than on MTS. 
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Table 7. Minimum inhibitory concentration (MIC) values of 
selected antimicrobials for Tay/ore/la sp. 
Antimicrobial MIC value (µg/ml) 
Amphotericin B 160 
Clindamycin 20 
Cloxacillin <0.625 
Ethambutol >1280 
lsoniazid 640 
Li neomycin 40 
Metronidazole 40 
Nafcillin <0.625 
Oxacillin 1.25 
p-aminosalicyclic acid 1280 
Trimethoprim 2.5 
32 
DISCUSSION 
The objective of this study was to develop an improved selective medium for the isolation of 
Tay/ore/la sp .. Various methods can be utilized to determine an organism's response to an 
antimicrobial. Disk diffusion was used in this study. It is generally assumed that the smaller 
the zone of inhibition the less the antimicrobial effects the growth of the organism in vitro, 
but due to other factors the zone of inhibition does not always correlate with MIC value. 
Since certain drugs diffuse faster into the agar than others, the zone of inhibition may be 
larger but this may not be indicative of the MIC. To determine which antimicrobials had the 
smallest zones of inhibition to Tay/ore/la sp., and therefore, were candidates for inclusion 
into a new selective medium, disk diffusion testing was performed. Because there are no 
standard procedures for susceptibility testing of Tay/ore/la sp. , it was necessary to work 
within the organisms requirements to design an alternative method of testing. The optimum 
environment for the growth of Tay/ore/la sp. is 5-10% CO2. All isolation of Tay/ore/la sp. in 
diagnostic laboratories takes place in this environment, so it was necessary to perform 
susceptibil ity testing using 5-10% CO2. In past studies susceptibility testing for Tay/ore/la 
sp. had been performed in 5-10% CO2 (6, 8, 9, 15, 26, 31) with the possible exception of one 
study (40) where the authors did not state the environmental conditions for plate incubation. 
Disk diffusion testing could not be completed for all isolates for trovafloxacin, 
sulfachloropyradizine, and sulfadimethoxine with ormetoprim due to the discontinuation of 
the disks. The zones of inhibition obtained from the isolates tested were large and 
assuming the pattern continued , the antimicrobials would not have been candidates for 
inclusion into an improved selective medium. 
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To ensure diagnostic proficiency it is necessary to have a medium that will support growth of 
the organism one wishes to recover. In diagnostic testing for Tay/ore/la sp. it is accepted 
procedure to utilize two media, one that is non inhibitory and another that is selective. 
Because the caudal reproductive tract of the horse can be host to a high number of 
microorganisms, the use of two plates increases the opportunity to isolate the fastidious 
pathogen. The selective medium serves to restrict the growth of contaminating 
microorganisms. If the selective medium can maintain the same characteristics of the non-
inhibitory medium, while inhibiting competing organisms, the plate will be useful in the 
recovery of Tay/ore/la sp. from heavily contaminated sites. Eugon agar with 10% chocolate 
horse blood (without added glucose) greatly improves recovery of Tay/ore/la sp., so it was 
chosen by this author as the basal medium under the premise that its growth promoting 
activities would overcome any effect the antimicrobials may have on the organism (11 ). 
Glucose was excluded from the Eugon agar because it is not metabolically utilized by 
Tay/ore/la sp. and because it promotes the growth of some glucose fermenting bacterial 
contaminants, such as E. coli (40). Some work has been performed using agar dilution 
testing with a Eugon base without added glucose and included a supplement, lsolvitalex, 
that was later found to have no significant growth promoting properties, so it was removed 
(2, 40, 41 ). In addition, other researchers utilized Eugen agar as the basal medium for agar 
dilution susceptibility testing (8, 15, 31 ). There is no mention of the exclusion of glucose 
from the Eugen agar by these researchers probably because they were not interested in 
developing a selective medium (8, 15, 31 ). Eugen agar and Mueller-Hinton agar with 5% 
defibrinated horse blood were utilized by some researchers in disk diffusion testing, and 
both were found to work equally well (26). The purpose of their research was to provide 
some basis for the use of antibiotics for treatment, so the inclusion of glucose and the basal 
medium used were inconsequential. If they were only measuring MIC levels (or disk 
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diffusion in the case of these researchers) of Tay/ore/la sp., presumably in pure culture, 
there were no contaminants to be inhibited, so the inclusion of glucose would be 
inconsequential (26). 
Other authors have chosen to use other basal media for susceptibility testing. One author 
chose Mueller-Hinton agar supplemented with 1 % Fildes enrichment for disk diffusion and 
agar dilution testing (6). However, the author was exploring treatment options for Tay/ore/la 
sp. and was not trying to develop a selective medium, so it was unnecessary to select a 
medium on which Tay/ore/la sp. thrive because the in vivo action of the drug was the 
important consideration(6). Researchers used lso-Sensitest agaf with 5% lysed horse 
blood for agar dilution testing (9). Again, they were investigating active drugs and MIC 
breakpoints for isolates from individual patients and were not concerned with growth of the 
organism in vitro. 
The Tay/ore/la organism grows slowly, but acceptable growth is present at 48 hours post 
inoculation, so susceptibility results were read after 2 days of incubation in this study. It was 
noted by one author who read disk diffusion plates at 24 hours after inoculation, that an 
additional 24 hours increased the amount of growth seen, but did not decrease the zone of 
inhibition size (26). Although one author did not report when results were read, others read 
susceptibility results at 48 hours post inoculation (8, 9, 15, 31, 40). Susceptibility results 
were read by one author at 72 hours post inoculation (6). In the current study, three 
replications of disk diffusion testing were performed on each isolate against every drug. The 
mean of the values for all replications for all isolates was used, reducing the potential for 
errors in zone size measurements. 
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The most recent antimicrobial susceptibility testing on Tay/ore/la sp. was performed in 1993. 
Because T. asinigenitalis was not isolated until 1998, the current research was the first in 
which antimicrobial susceptibility testing was performed on T. asinigenitalis. These data are 
crucial when developing a new selective medium that will be used for isolation of both 
T. equigenitalis and T. asinigenitalis. 
The most recent paper dealing directly with the development of a selective medium for the 
isolation of T. equigenitalis was published in 1982 (9, 40). To ensure that recently 
discovered antimicrobials with the potential to improve the selective medium for isolation of 
Tay/ore/la sp. are considered, it is necessary to perform antimicrobial sensitivity testing at 
appropriate time intervals. New antimicrobials are constantly being discovered. If testing is 
not done, a new antimicrobial that may have ideal properties for use in a selective medium 
for Tay/ore/la sp. isolation would be unutilized. 
In this study, forty-nine antimicrobials were tested against Tay/ore/la sp. for the first time. 
The newly tested group of forty-nine antimicrobials contributed five of the ten antimicrobials 
chosen for further investigation based on the lowest mean zone of inhibition. Many 
antimicrobials within classes were tested because it is conceivable that one member of the 
class has properties that make it a better candidate than other members of the class. For 
example, if researchers tested a few aminoglycosides and excluded all others based on 
T. equigenitalis being susceptible to just one member of the class, they would have not 
discovered that T. equigenitalis was resistant to streptomycin. 
In order to detect all strains of Tay/ore/la sp. in this study, it was necessary to use a MIC100 
and state that 100% of strains tested were found to be resistant. Other authors gave MICso 
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and MICso values because they were interested if the strain of Tay/ore/la was susceptible to 
a given antimicrobial for treatment purposes (6, 9, 15, 31 ). Because both T. equigenitalis 
and T. asinigenitalis were used in the current study, the MIC values chosen were lower than 
if only T. equigenitalis were used. Based on results from the disk diffusion testing, there is a 
difference in the sensitivity to some antimicrobials between T. equigenitalis and 
T. asinigenitalis. Tay/ore/la asinigenitalis was significantly more sensitive to the penicillins. 
Diagnostic plate media are frequently overgrown with contaminating bacteria. Because 
fungal overgrowth is rarely a problem on MTS, a decision was made to continue using the 
anti-fungal agent, amphotericin B, instead of trying to find an alternative anti-fungal agent. 
The amount of amphotericin B required to inhibit fungal growth according to a previous 
study was 5 µg/ml while the MIC for Tay/ore/la sp. determined in this study was 160 µg/ml 
(40). 
To determine MIC levels a broad range of dilutions was used initially because no known 
MIC values were available for Tay/ore/la sp. to many of the antimicrobials tested. Based on 
the formulation of MTS, it was possible to determine a narrower range of MIC values for 
clindamycin, trimethoprim and amphotericin B (40). Published MIC results were available 
for lincomycin and cloxacillin (6, 9, 15, 31). 
Cloxacillin, ethambutol, lincomycin, isoniazid, and p-aminosalicyclic acid did not have quality 
control organisms with known MIC values, so five quality control organisms referenced in 
NCCLS were used to determine if the three replications to obtain the MIC produced the 
same pattern of results. This does not, however, prove that the concentration of the 
antimicrobials was accurate, but the analysis that would provide that information was too 
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expensive and time-consuming to incorporate in this project. The proof that trimethoprim , 
clindamycin , nafcillin, oxacillin, metronidazole, and amphotericin B were added in the stated 
concentrations was from quality control organisms with known MIC values. These MIC 
values were obtained from agar dilution testing of analyzed levels of antimicrobials which 
were incorporated into an agar base. 
When clindamycin and trimethoprim stock solutions were incorporated into Eugen agar and 
incubated in CO2, the quality control organisms did not produce known MIC values. Utilizing 
Eugen agar or incubating in CO2 affected the MIC results. By removing both of these 
factors and incorporating the stock solution in Mueller Hinton agar, the stock solution was 
tested for efficacy. The quality control values obtained from the Mueller Hinton plates with 
each antimicrobial indicated the correct concentration of stock solution was incorporated into 
the Eugen base. 
To determine the types of bacteria most commonly found in the equine reproductive tract, 
swabs were obtained from diagnostic laboratories across the country. Any regional 
variation in flora would be accounted for by having representative samples of flora from 
across the country. One author stated that the following bacteria are associated with the 
external genitalia of the mare or stallion: staphylococci , streptococci , Bacillus species, 
diphtheroids, E. coli, K/ebsiel/a pneumoniae, Proteus mirabilis, and Pseudomonas species 
(40). The author did not state if there was any research to determine this, or if it was from 
another source that was not referenced. Six of the ten most frequently identified 
contaminants from the present study are on the list provided by the previous author (40). 
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Swabs from outside diagnostic laboratories were shipped on dry ice in their original 
transport medium and frozen at -70°C. There may have been a loss of some of the 
contaminants, but they may have been the more fastidious contaminants. These 
contaminants may not have been an issue since they may not have been able to overgrow 
Tay/ore/la sp .. 
In addition, there were contaminants that could not satisfactorily be identified by Sensititre's 
data base. Perhaps these isolates were not normally found and, therefore, were not in the 
database. If the most frequently isolated contaminants could be used to screen the new 
medium, additional side by side testing with MTS could occur to compare the two using the 
plethora of contaminants contained in field diagnostic samples. 
The MIC levels were determined for Tay/ore/la sp. to the ten antimicrobials with the lowest 
mean zones of inhibition. Instead of determining MIC values for each contaminant, the MIC 
of Tay/ore/la sp. to each antimicrobial was used as the last dilution that the contaminants 
were tested against. Thus, if the contaminant could not be inhibited by the level of 
antimicrobial that Tay/ore/la sp. could still survive, it was discounted as a candidate and 
determining an MIC at that point became unnecessary. The contaminants were incubated 
in CO2 to provide the environment that would be utilized to isolate Tay/ore/la sp. Because 
the contaminants were not fastidious, MIC results were read at 24 hours post inoculation. 
Amphotericin B did not inhibit any of the bacterial contaminants. The mode of action of 
amphotericin B involves binding to ergosterol in the fungal cell membrane, resulting in pores 
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being produced causing cell leakage and ultimately cell death; ergosterol is unique to fungi 
so amphotericin B has no effect on bacteria. 
Clindamycin and lincomycin were equally effective at inhibiting the highest percentage of the 
ten most common contaminants. Clindamycin was better than lincomycin at controlling 
growth of selected Gram positive bacteria, which was supported by results from the present 
study (40). Based on agar dilution testing of the contaminants they were equal in restricting 
growth of the ten most common contaminants individually. When they were incorporated 
into media in combination with other antimicrobials and the ten most common contaminants 
were streaked individually and in combinations, clindamycin seemed to be superior. 
Clindamycin is generally thought of as being more potent that lincomycin , which may explain 
the lower MIC value of Tay/ore/la sp. to clindamycin than lincomycin. The lincosamides 
inhibit bacterial protein biosynthesis of Gram positive organisms as a result of interaction 
with the bacterial ribosome by binding the 50S subunit. 
Cloxacillin, oxacillin, and nafcillin are all in the penicillin class and inhibit bacterial cell wall 
synthesis by interfering with murein transpeptidase enzymes responsible for the formation of 
cross links between peptidoglycan. They act on Gram positives, Gram negative cocci, and a 
few Gram negative bacilli. 
Ethambutol is an anti-tuberculosis drug with an unknown mode of action. It had a very high 
MIC against Tay/ore/la sp., but only inhibited one of the ten most frequently identified 
contaminants. Because other antimicrobials could inhibit that same contaminant plus 
others, ethambutol was excluded. 
lsoniazid is an anti-tuberculosis drug that disrupts mycolic acid biosynthesis. It, like 
ethambutol, had a relatively high MIC against Tay/ore/la sp., but only inhibited one of the ten 
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most frequently identified contaminants. Because other antimicrobials could inhibit that 
same contaminant plus others, isoniazid was excluded. 
Metronidazole is a nitroimidazole that targets cytoplasmic enzymes and protein involved in 
respiration and disrupts pyruvate and glucose metabolism. It acts mainly on anaerobic 
bacteria and protozoa. It, like ethambutol and isoniazid, had a relatively high MIC against 
Tay/ore/la sp., but only inhibited one of the ten most frequently identified contaminants. 
Because other antimicrobials could inhibit that same contaminant plus others, metronidazole 
was excluded. 
P-aminosalicyclic acid is an anti-tuberculosis drug that inhibits bacterial folate metabolism. It 
was chosen because it inhibited two of the three contaminants that lincomycin and 
clindamycin could not, and because it had a large MIC against Tay/ore/la sp .. 
Trimethoprim is a diaminopyrimidine that disrupts normal bacterial folic acid metabolism. 
The MIC of Tay/ore/la sp. against trimethoprim was 2.5 µg/ml. None of the ten most 
frequent contaminants were inhibited at levels equal to or below this level. Furthermore, it is 
currently incorporated in MTS at a level of 1 µg/ml. It may be necessary to reconsider 
adding trimethoprim to any medium used to isolate T. asinigenita/is since inclusion at a rate 
so close to the MIC does not provide a large margin of error. 
Because clindamycin and lincomycin were effective at inhibiting a high number of 
contaminants, they were chosen for further study. These two antimicrobials did not inhibit 
two of the ten contaminants, however p-aminosalicyclic acid inhibited one of the two. One 
contaminant was not inhibited by any of the antimicrobials. Amphotericin B was chosen as 
the antifungal agent. Three combinations were chosen: p-aminosalicyclic acid, lincomycin, 
and amphotericin B; p-aminosalicylic acid, clindamycin, and amphotericin B; and 
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clindamycin and amphotericin B. The third combination (MTS without the trimethoprim) was 
chosen primarily to see if the combination inhibited these ten contaminants when 
trimethoprim was removed, without the help of p-aminosalicyclic acid. Dilutions for p-
aminosalicyclic acid were formulated so that the highest dilution fell two dilutions below the 
MIC for Tay/ore/la sp., the next three below, and the next four below. A margin of safety of 
two dilutions below the MIC100 for Tay/ore/la sp. should be adequate to prevent any loss of 
growth. Clindamycin was included in MTS at the level of 5 µg/ml , which was a two-fold 
dilution below the MIC. Contaminant 7 (Enterococcus sp.) was not inhibited by less than 5 
µg/ml of clindamycin, so in order for the organism to be inhibited on the plates, clindamycin 
had to be added at that concentration. Lincomycin is purported to be less potent than 
clindamycin, so the levels of lincomycin were not varied . Only the highest dilution of 
lincomycin, two below the MIC, was utilized to see if it was as inhibitory to the contaminants 
as clindamycin . 
The antimicrobial combinations were made and incorporated into a Eugen base, without 
added glucose. A 10 µI loop of each contaminant, one strain of T. equigenitalis and one 
strain of T. asinigenita/is was streaked on to each of the dilutions for each combination and 
on to a MTS for comparison. One strain of T. equigenitalis was chosen arbitrarily to 
represent the other cultures. The T. asinigenita/is that was chosen was the most fastidious 
of all tested therefore, it would have a lower level of tolerance for the antimicrobials. The 
method chosen to evaluate growth on the plates was the quadrant system. There are other 
ways of rating growth on plates, such as colony counts, but the quadrant system was 
chosen for practicality due to the large volume of plates. In the only research detailing the 
development of a selective medium, the author did not detail what was done to rate growth 
on plates, and there is no other literature that dealt with development of a selective medium 
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in which this would have been described (40) . Diagnostic plates must be held for seven 
days according to federal regulations. The more contaminant growth that is inhibited 
throughout the seven days the higher the probability of recovering Tay/ore/la sp., so results 
from day seven were used to evaluate the growth. Combination 2/dilution 1 proved superior 
to the others at inhibiting contaminants and allowing the two Tay/ore/la sp. to grow. 
Samples taken from eight horses (7 mares, 1 stallion) were utilized to provide a small test 
for combination 2/dilution 1 along side MTS. Swabs were taken from the same anatomical 
sites, placed in the same media , transported to the lab under the same conditions, and 
plated onto diagnostic medium as would have any diagnostic samples that would be 
received . By reducing any variation from normal, this method should provide results based 
on the actual performance of the media. Swabs were taken from mares while conducting a 
pregnancy check at a herd health visit. The only stallion available for swabbing was there to 
have semen collected and had been thoroughly cleaned before the swabs were taken. 
Therefore, the growth on plates was not similar to what is normally seen on diagnostic 
plates for stallions. It would be normal to see growth into the third and fourth quadrants on 
a swab from a stallion. Growth of 1 + was the maximum amount seen. However, equal 
amounts of growth were seen on MTS and combination 2/dilution 1, so the results of the 
study did not reflect any differences based on the stallion swabs. Plates were rated by the 
quadrant method. From this limited set of samples, combination 2/dilution 1 inhibited 
contaminants better than MTS. 
The goal of this project was to develop an improved medium for isolation of Tay/ore/la sp. It 
was beyond the scope of this research to test large numbers of diagnostic samples to more 
rigorously evaluate its performance for use as a replacement for MTS. A side-by-side 
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comparison of the new medium with the currently used MTS medium is recommended for 
further validation. 
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CONCLUSIONS 
For the United States to remain free of T. equigenita/is, diagnostic laboratories must be able 
to clearly read diagnostic plates. An improved selective medium that reduces the number of 
contaminants seen on plates would be a great asset in searching for colonies of Tay/ore/la 
sp .. The discovery of a new species and its addition to the genus Tay/ore/la meant new 
information vital to the use of selective media. MTS contains trimethoprim. The level of 
trimethoprim necessary to inhibit the growth of the ten most frequently identified 
contaminants was found to be too high to allow growth of both T. asinigenitalis and 
T. equigenitalis, thus suggesting that MTS is not an optimal medium. Because of the highly 
contaminated nature of the caudal equine reproductive tract, it is challenging to find 
antimicrobials that inhibit the normal flora, but also allow for the growth of Tay/ore/la sp .. 
The new combination of 320 µg/ml p-aminosalicyclic acid, 5 µg/ml clindamycin, and 5 µg/ml 
amphotericin B does a better job at inhibiting the ten most commonly found contaminants 
than does MTS. In addition, it appears to do better at inhibiting normal flora from swabs 
taken from the caudal equine reproductive tract. However, a side-by-side comparison of the 
new combination with MTS with a larger sample size is needed to evaluate its potential to 
replace MTS. 
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APPENDIX A. SUPPLEMENTAL DATA 
Table 1. Average Zones of Inhibition and ranges (mm) of 87 antimicrobials for 34 isolates of 
Tay/ore/la sp. 
Aminoglycosides Mean Range Other Mean Range 
Amikacin 30.24 0-55 Bacitracin 28.43 16-44 
Gentamvcin 28.57 20-55 Chloramphenicol 42.76 12-60 
Kanamvcin 30.82 21-50 Ethambutol 9.23 6-40 
Neomycin 29.32 21-50 lsoniazid 13.31 6-40 
Netilmicin 32.70 24-60 Novobiocin 25.19 12-43 
Streptomycin 19.05 0-48 p-aminosalicyclic acid 10.32 6-44 
Soectinomvcin 38.93 28-55 Vancomvcin 15.08 10-40 
Tobramycin 26.69 20-52 Penicillins 
Carbapenems Amindocillin 21 .84 0-50 
lmioenem 39.59 20-60 Amoxicillin w/ clavulanic acid 32.68 15-51 
Cephalosporins Ampicillin 38.13 10-60 
Cefaclor 26 .1 1 10-40 Amoicillin w/ sulbactam 34.57 20-58 
Cefamandole 36.34 25-52 Azlocillin 46.83 17-77 
Cefazolin 30.45 15-50 Aztreonam (related to B-lactams) 38.35 15-60 
Cefepime 42.57 26-63 Carbenicillin 44.59 25-64 
Cefixime 38.45 12-70 Cloxacillin 9.95 6-42 
Cefonicid 37 .12 15-55 Methicillin 15.21 0-31 
Cefoperazone 42.65 10-70 Mezlocillin 41 .38 19-70 
Cefotaxime 45.51 20-70 Nafcillin 11.15 6-50 
Cefoodoxime 41 .32 25-60 Oxacillin 10.44 6-40 
Cefprozil 29.19 0-50 Penicillin 35.65 12-60 
Ceftazidime 39.58 15-64 Piperacillin 41 .05 9-70 
Ceftiofur 41.84 18-62 Ticarcillin 45.55 30-70 
Ceftizoxime 38.98 22-60 Polymyxins 
Ceftriaxone 44.83 25-70 Colistin 23.19 15-45 
Cefuroxime 38.41 25-60 Polymyxin B 25.1 9 12-35 
Cephalothin 34.72 17-52 Quinolones/Fluroquinolones 
Loracarbef 28.20 0-44 Cinoxacin 41 .60 30-55 
Moxalactam 39.40 25-60 Ciprofloxacin 41 .68 25-70 
Cephamycins Enrofloxacin 48.32 31-65 
Cefmetazole 38.03 18-65 Enoxacin 40.55 0-60 
Cefotetan 40.32 17-60 Levofloxacin 41.42 30-55 
Cefoxitin 39.59 18-70 Lomefloxacin 39.48 25-60 
Diaminopyrimidines Nalidixic acid 36.1 8 20-50 
Trimethoprim 14.40 6-44 Norfloxacin 37.58 15-52 
Lincosamides Ofloxacin 38.31 20-60 
Clindamvcin 9.57 6-33 Oxolinic acid 27.47 17-60 
Lincomycin 9.48 6-30 Sparfloxacin 44.91 30-70 
Macrolides/Rifamycins Trovafloxacin * 36.39 25-50 
Azithromvcin 45.67 30-70 Sulfonamides/Com bi nations 
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Table 1. Continued 
Macrolides/Rifamycins Mean Range Sulfonamides/Combinations Mean Range 
Clarithromycin 48.52 15-75 Sulfachloropyridazine * 35.48 29-57 
Erythromycin 47.14 22-70 Sulfadimethoxine w/ ormetoprim * 28.47 20-45 
Rifampin 27.94 15-50 Sulfisoxazole 39.15 12-70 
Tilmicosin 44.45 15-60 Sulphamethoxazole w/ trimethoprim 33.05 20-54 
N itrofu rans/N itroi m idazoles Triple Sulfa 37.25 0-68 
Furazolidone 44.58 15-60 Tetracyclines 
Metronidazole 6.00 6-6 Doxycycline 42.41 28-60 
Nitrofurantoin 48.91 18-60 Minocycline 41 .94 30-60 
Nitrofurazone 54.18 27-80 Oxytetracycline 39.88 26-60 
Tetracycline 40.68 28-60 
*Testing not completed due to discontinuation of the product 
Table 2. P-values for T. equigenitalis compared to 
T. asinigenitalis 
Antimicrobial p-value 
Clindamycin 8.697 X 104 
Cloxacillin 1.006 X 10-4 
lsoniazid 0.0475 
Li neomycin 0.0480 
Nafcillin 4.672x 10-5 
Oxacillin 2.516 X 10-5 
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Table 3. Organisms identified by Sensititre 
Bacillus sp. 
CDC VE type 1 
Citrobacter freundii 
Enterobacter aerogenes 
Enterobacter sakazakii 
Enterococcus faecalis 
Enterococcus faecium 
Enterococcus sp. 
Escherichia coli 
Gardnerella vagina/is 
Klebsiel/a ozaenae 
Kluyvera ascorbata 
Kocuria rosea 
Micrococcus sp. 
Moraxella osloensis 
Pantoea aqq/omerans 
Pasteurella multocida 
Pseudomonas pseudoa/caligenes 
Salmonella sendai 
Sphingomonas paucimoblis 
Staphylococcus aureus 
Staphylococcus epidermidis 
Staphylococcus haemolvticus 
Staph y/ococcus intermedius 
Staphylococcus sp. (non-hemolytic) 
Staphylococcus xylosus 
Streptococcus equi ssp. zooepidemicus 
Streptococcus mitis 
Streptococcus sp. 
Streptococcus uberis 
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Table 4. Inhibition (uglml) by antimicrobials of ten contaminants 
Contaminant No.* Antimicrobial 
Amphotericin B Clindaymycin Cloxacillin Ethambutol 
1 >160 <5 <0.625 >1280 
2 >160 <5 <0.625 >1280 
3 >160 <5 >0.625 >1280 
4 >160 >20 >0.625 >1280 
5 >160 >20 >0.625 <640 
6 >160 <5 <0.625 >1280 
7 >160 5 >0.625 >1280 
8 >160 10 >0.625 >1280 
9 >160 <5 <0.625 >1280 
10 >160 <5 >0.625 >1280 
*1 = Staphylococcus aureus, 2= Staphylococcus haemolyt1cus; 
3= non hemolytic Streptococcus sp.; 4= Escherichia coli; 5= Enterobacter aerogenes; 
6= Micrococcus sp.; 7= Enterococcus sp.; 8= Moraxe/fa os/oensis; 
9= Streptococcus equi ssp. zooepidemicus; 1 0= Staphylococcus xylosus 
lsoniazid 
>640 
>640 
>640 
>640 
<640 
>640 
>640 
>640 
>640 
>640 
Li neomycin 
<20 
<20 
<20 
>40 
>40 
<20 
<20 
40 
<20 
<20 
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Table 4. Continued 
Contaminant No.* Antimicrobial 
Metronidazole Nafcillin Oxacillin p-aminosalicvclic acid 
1 >160 >0.625 1.25 >1280 
2 >160 <0.625 <0.625 >1280 
3 >160 >0.625 1.25 >12801 
4 >160 >0.625 >1 .25 >1280 
5 <0 .1 >0.625 >1 .25 <320 
6 >160 <0.625 <0.625 >1280 
7 >160 >0.625 >1 .25 >1280 
8 >160 >0.625 >1 .25 <320 
9 >160 <0.625 <0.625 >1280 
10 >160 <0.625 1.25 >1280 
*1 = Staphylococcus aureus, 2= Staphylococcus haemolyt,cus; 
3= non hemolytic Streptococcus sp.; 4= Escherichia coli; 5= Enterobacter aerogenes; 
6= Micrococcus sp.; 7= Enterococcus sp.; 8= Moraxella osloensis; 
9= Streptococcus equi ssp. zooepidemicus; 1 O= Staphylococcus xylosus 
Trimethoprim 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
>2.5 
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Table 5. Antimicrobial inhibition of contaminants 
Contaminant no.* 
Antimicrobial 1 2 3 4 5 6 7 8 9 10 
Amphotericin B 
Clindamycin X X X X X X X X 
Cloxacillin X X X X 
Ethambutol X 
lsoniazid X 
Lincomycin X X X X X X X X 
Metron idazole X 
Nafcillin X X X X 
Oxacillin X X X X X X 
p-aminosalicyclic acid X X 
Trimethoprim 
*1 = Staphylococcus aureus, 2= Staphylococcus haemolyticus; 
3= non hemolytic Streptococcus sp.; 4= Escherichia coli; 5= Enterobacter aerogenes; 
6= Micrococcus sp.; 7= Enterococcus sp.; 8= Moraxella osloensis; 
9= Streptococcus equi ssp. zooepidemicus; 1 O= Staphylococcus xylosus 
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Table 6. Modified Timoney Shin (MTS) compared to different combinations and dilutions of antimicrobials 
with contaminants and Tay/ore/la sp. using quadrant scores 
C1/D1 C1/D2 C1/D3 C2/D1 C2/D2 C2/D3 C3/D1 C3/D2 MTS 
Contaminant 1 2+ 2+ 2+ 1+ 2+ 2+ 2+ 2+ 4+ 
Contaminant 2 1+ 1+ NG NG NG NG NG NG 1 col 
Contaminant 3 NG 1 col 1 col NG NG NG NG NG 1 col 
Contaminant 4 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
Contaminant 5 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
Contaminant 6 1+ 1+ 1+ NG NG 1+ NG 1+ 1+ 
Contaminant 7 4+ 4+ 4+ 2+ 4+ 4+ 3+ 3+ 2+ 
Contaminant 8 4+ 4+ 4+ NG 2+ 4+ 2+ 2+ 1+ 
Contaminant 9 1+ NG NG NG NG NG NG NG 1 col 
Contaminant 10 2+ 4+ 4+ 1+ 4+ 2+ 1+ 2+ 1+ 
T. equiaenitalis (10) 3+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
T. asiniaenitalis (22) 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
C=combinat1on, D=d1lut1on, col=colony, NG=no growth 
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Table 7. Modified Timoney Shin (MTS) compared to combination 2/dilution 1 (C2D1) of new medium with 
contaminants and Tay/ore/la sp. using quadrant scores 
Day 1 Dav 3 Dav4 Dav5 Dav 7 
MTS C2D1 MTS C2D1 MTS C2D1 MTS C2D1 MTS C2D1 
Contaminant 1 4+ <1+ 4+ 1+ 4+ 1+ 4+ 1+ 4+ 1+ 
Contaminant 2 1+ NG 2+ NG 2+ NG 2+ NG 2+ NG 
Contaminant 3 3+ NG 3+ NG 3+ NG 3+ NG 3+ NG 
Contaminant 4 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
Contaminant 5 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
Contaminant 6 NG NG NG NG NG NG NG NG NG NG 
Contaminant 7 4+ NG 4+ 2+ 4+ 2+ 4+ 2+ 4+ 2+ 
Contaminant 8 3+ NG 3+ <1+ 3+ <1+ 3+ <1+ 3+ <1+ 
Contaminant 9 2+ NG 2+ NG 2+ NG 2+ NG 2+ NG 
Contaminant 10 1+ NG 3+ NG 3+ NG 3+ NG 3+ NG 
Combination 1 2+ 1+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
Combination 2 1+ 1+ 1+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
Combination 3 1+ <1+ 1+ <1+ 1+ <1+ 1+ <1+ 1+ <1+ 
Combination 4 1+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
Combination 5 2+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
Combination 6 1+ 1+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
Combination 7 2+ 2+ 3+ 2+ 3+ 2+ 3+ 2+ 3+ 2+ 
Combination 8 1+ 1+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
Combination 9 2+ NG 2+ NG 2+ 1 col 2+ 1 col 2+ 1 col 
Combination 10 1+ NG 1+ NG 1+ NG 1+ NG 1+ NG 
Combination 11 1+ NG 1+ NG 1+ 2 col 1+ 2 col 1+ 2 col 
Combination 12 2+ NG 2+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
Combination 13 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 1+ 
Combination 14 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
Combination 15 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
Combination 16 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 2+ 
T. eauiqenitalis (10) NG NG 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
T. asinigenitalis (22) NG NG 4+ 4+ 4+ 4+ 4+ 4+ 4+ 4+ 
col=colony, NG=no growth 
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Table 8. Modified Timoney Shin (MTS) compared to combination 
2 dilution 1 (C2D1) of new media with diagnostic samples using 
quadrant scores 
Day 1 Day 2 Day3 Day4 
Anatomical site 
of swab MTS C2D1 MTS C2D1 MTS C2D1 MTS C2D1 
2S 1+ 1+ 2+ 2+ 2+ 2+ 2+ 2+ 
2F 1+ 1+ 2+ 2+ 2+ 2+ 2+ 2+ 
2C 2 col 3 col 1+ 3 col 1+ 3 col 1+ 3 col 
9S 1+ 1 col 2+ 1 col 2+ 1 col 2+ 1 col 
9F 1+ 5 col 3+ 5 col 3+ 5 col 3+ 5 col 
9C 1 col NG 1+ NG 1+ NG 1+ NG 
11S 1+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
11 F 1+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
11C 3col 1+ 1+ 1+ 1+ 1+ 1+ 1+ 
13S 1+ 1+ 3+ 1+ 3+ 1+ 3+ 2+ 
13F 1+ 1+ 3+ 2+ ~+ 2+ ~+ 2+ 
13C 2+ 1+ 4+ 2+ ~+ 2+ ~+ 2+ 
28S 2+ 2+ 3+ 2+ ~+ 2+ ~+ 2+ 
28F 2+ 4+ 2+ 4+ 3+ 4+ 3+ 4+ 
Spice S 10 col 5 col 3+ 1+ 3+ 1+ 2+ 1+ 
Spice F 1+ 1+ 2+ 1+ 2+ 1+ 2+ 1+ 
Spice C NG 1+ 1+ 1+ 2+ 1+ 2+ 1+ 
~ioov S 1+ 2+ 3+ 2+ 3+ 2+ 3+ 2+ 
~ippy F 3+ 2+ 4+ 2+ 4+ 2+ 4+ 2+ 
Stal UF NG 5 col 2 col 1+ 1+ 1+ 1+ 1+ 
Stal U NG NG NG NG 1 col NG 1 col NG 
Stal Div 3col 1+ 1+ 1+ 1+ 1+ 1+ 1+ 
S=chtoral sinus, F=chtoral fossa, C=cerv1x, UF=urethral fossa, U=urethra, 
Div=diverticulum, C=combination, D=dilution, col=colony, NG=no growth 
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Table 8. Continued 
Day 5 Day6 Day 7 
MTS C2D2 MTS C2D3 MTS C2D4 
2S 2+ 2+ 2+ 2+ 2+ 2+ 
2F 2+ 2+ 2+ 2+ 2+ 2+ 
2C 1+ 3 col 1+ 3 col 1+ 3 col 
9S 2+ 1 col 2+ 1 col 2+ 1 col 
9F 3+ 5 col 3+ 5 col 3+ 5 col 
9C 1+ NG 1+ NG 1+ NG 
11S 2+ 1+ 2+ 1+ 2+ 1+ 
11 F 2+ 1+ 2+ 1+ 2+ 1+ 
11C 1+ 1+ 2+ 1+ 2+ 1+ 
13S 3+ 4+ 3+ 4+ 3+ 4+ 
13F 4+ 2+ 4+ 2+ 4+ 2+ 
13C 4+ 2+ 4+ 2+ 4+ 2+ 
28S 4+ 2+ 4+ 2+ 4+ 2+ 
28F 3+ 4+ 3+ 4+ 3+ 4+ 
Spice S 2+ 1+ 2+ 1+ 2+ 1+ 
Spice F 2+ 1+ 2+ 1+ 2+ 1+ 
Spice C 2+ 1+ 2+ 1+ 2+ 1+ 
Zioov S 3+ 2+ 3+ 2+ 3+ 2+ 
ZiPPV F 4+ 2+ 4+ 2+ 4+ 2+ 
Stal UF 1+ 1+ 1+ 1+ 1+ 1+ 
Stal U 7 col NG 7 col NG 7 col NG 
Stal Div 1+ 1+ 1+ 1+ 1+ 1+ 
S=clitoral sinus, F=clitoral fossa, C=cervix, UF=urethral fossa, U=urethra, 
Div=diverticulum, C=combination, D=dilution, col=colony, NG=no growth 
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APPENIDIX 8. LIST OF MEDIA 
Eugon agar 
Eugon agar (BBL) 45g 
Sterile water 900ml 
Defibrinated horse blood 100 ml 
Modified Timoney-Shin 
Tryptone peptone (Difeo) 15g 
Phytone peptone (BBL) 5g 
Sodium chloride 4g 
Sodium sulfite 0.2g 
L-cystine 0.7g 
Bacto agar 15g 
Sterile water 900ml 
Defibrinated horse blood 100ml 
Trimethoprim 1 µg/ml 
Clidamycin Sµg/ml 
Fungizone Sµg/ml 
New Formulation (Combination 2/Dilution 1) 
T ryptone peptone (Difeo) 15g 
Phytone peptone (BBL) 5g 
Sodium chloride 4g 
Sodium sulfite 0.2g 
L-cystine 0.7g 
Bacto agar 15g 
Sterile water 900ml 
Defibrinated horse blood 100ml 
Clindamycin 5 µg/ml 
Amphotericin B 5 µg/ml 
p-aminosalicyclic acid 320 µg/ml 
56 
APPENDIX C. LIST OF COMMERCIAL PRODUCTS 
a. API ZYM, bioMerieux sa 69280 Marcy l'Etoile-France 
b. Amies Transport medium with charcoal , Copan Italia S.p.a. Via F. Perotti 10, 25125 
Brescia-Italy 
c. lsovitalex, Becton Dickinson Microbiology Systems Sparks, Maryland 21152 USA 
d. Oxoid lso-Sensitest agar, Oxoid Limited Wade Road Basingstoke Hants RG24 8PW-
England 
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